Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Private Advisor Group LLC

Private Advisor Group LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 22.0% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,655 shares of the biotechnology company’s stock after selling 2,727 shares during the quarter. Private Advisor Group LLC’s holdings in Axon Enterprise were worth $5,738,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. ICICI Prudential Asset Management Co Ltd acquired a new position in Axon Enterprise in the 4th quarter valued at $590,000. Financial Management Network Inc. grew its stake in shares of Axon Enterprise by 10.0% during the 4th quarter. Financial Management Network Inc. now owns 550 shares of the biotechnology company’s stock worth $331,000 after purchasing an additional 50 shares during the period. TimesSquare Capital Management LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth $33,240,000. Global Retirement Partners LLC grew its stake in shares of Axon Enterprise by 23.1% during the 4th quarter. Global Retirement Partners LLC now owns 974 shares of the biotechnology company’s stock worth $579,000 after purchasing an additional 183 shares during the period. Finally, Bank of Jackson Hole Trust acquired a new position in shares of Axon Enterprise during the 4th quarter worth $79,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $513.22 on Friday. The company has a market cap of $39.13 billion, a PE ratio of 132.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $265.32 and a 12 month high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a 50-day simple moving average of $619.94 and a 200-day simple moving average of $518.66.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the sale, the insider now directly owns 124,243 shares of the company’s stock, valued at approximately $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,711 shares of company stock worth $5,631,561 over the last ninety days. 6.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on AXON. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $561.31.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.